Human medicines European public assessment report (EPAR): Aerinaze, desloratadine,pseudoephedrine, Date of authorisation: 30/07/2007, Revision: 23, Status: Authorised
Public engagement highlights 2025
Human medicines European public assessment report (EPAR): Zokinvy, lonafarnib, Date of authorisation: 18/07/2022, Revision: 4, Status: Authorised
Pharmacovigilance Risk Assessment Committee (PRAC): 7-10 April 2026, European Medicines Agency, Amsterdam, the Netherlands, from 7 April 2026 to 10 April 2026
European Medicines Agency's data protection notice for the implementation of the Instrument for Pre-accession Assistance (IPA) programme
SPOR and XEVMPD status update webinar - Q2 2026, Online, European Medicines Agency, Amsterdam, the Netherlands, from 13 April 2026, 10:00 (CEST) to 13 April 2026, 12:30 (CEST)
Industry Standing Group
Highlights - EMA - European Alliance of Associations for Rheumatology (EULAR) bilateral meeting - March 2026
Electronic application form (eAF) Q&A clinic, Online, European Medicines Agency, Amsterdam, the Netherlands, from 9 March 2026, 11:00 (CET) to 9 March 2026, 12:00 (CET)
Notices and alerts per role - CTIS Training Programme - Module 07